BIT's 17th Annual Congress of International Drug Discovery Science & Technology-China 2019
★ Scientific Program
 

BIT’s 17th Annual International Congress of

 

Drug Discovery Science & Technology 2019

 

Theme: The Disruptive, Integrate, Innovation and Development

 

Time: November 15-17, 2019   

 

Place: Nanjing, China

 

Important Activities

Scientific Program

Project Matchmaking

Keynote Forum

Stream 7

Stream 8

Stream 9

Stream 10

Plenary Talk

Stream 11

Stream 12

Stream 13

Stream 14

 

Scientific Program

Stream 11 New Biomodality Bay

Stream 1101: New Biotherapy Discovery
Time: 08:30-11:50, Nov 16, 2019(Saturday)
Place: FUNCTION ROOM 1, 3rd Floor, HOTEL UNIC

Chair: Dr. Kiyoshi Nokihara, CEO&CSO, HiPepLaboratories, Japan 

Co-Chair: Dr. Garry L. Taylor, Professor, University of St Andrews, UK

Time

Face On

Speeches and Speakers

08:30-08:35

Chair's Introduction

08:35-09:00

Keynote Speaker:
Title:
Adjuvant- and Cell-based Vaccine Approaches for Attacking Metastatic Carcinomas
Dr. Ningsun Yang,
Distinguished Research Fellow and Chair Professor, Academia Sinica, Taiwan

09:00-09:20

Title: Improved Design and Chemical Syntheses of Angiogenic Peptides focusing on Clinical Applications for the Regenerative Medicine
Dr. Kiyoshi Nokihara,
CEO&CSO, HiPepLaboratories, Japan

09:20-09:40 Title: Novel Human Therapeutic Immunoagents
Dr. Claudia De Lorenzo,
Associate Professor, University of Naples, Italy

09:40-10:00

Title: Gene Therapy for Treating Corneal Scar and Blindness
Dr. Rajiv R. Mohan,
Professor, University of Missouri, USA

10:00-10:20

 

Title: Multivalent Carbohydrate-binding Domains; A New Class of Biologics
Dr. Garry L. Taylor, Professor, University of St Andrews, UK

 

10:20-10:30

Coffee Break

10:30-10:50
Title: Analytical Technology Used in the Latest Development of Gene Therapy Candidates
Dr. Zhenhong Li, Senior Director, REGENXBIO Inc., USA
 
10:50-11:10

Title: Break Limits of Drugs and Cure Multiple Diseases with Neo-antigen Products
Dr. Yong Qian, Chairman, BioMedicure Group, USA and China

11:10-11:30
Title: Next Generation of Antibody with Long lasting Efficacy
Dr. Le Sun, President & CEO, AbMax Biotechnology Co. China
11:30-11:50

Title: Evolution of Adeno-associated Virus for Human Gene Therapy
Dr. Lin Yang,
Professor, State Key Laboratory of Biotherapy, Sichuan University, China

  

Stream 1102: Natural Products Drug Discovery and Therapy
Time: 10:45-12:50, Nov 17, 2019(Sunday)
Place: FUNCTION ROOM 4, 3rd Floor, HOTEL UNIC

Chair: Dr. Robert Borris, Vice-Dean, School of Pharmaceutical Science and Technology, Tianjin University, China

Time

Face On

Speeches and Speakers

10:45-10:50

Chair's Introduction

10:50-11:10

Title: Discovery and Development of Eribulin, A Macrocyclic Ketone Analog of Marine Sponge Natural Product Halichondrin B
Dr. Bruce A. Littlefield, Distinguished Scientist and Head, Translational Medicine, Global Oncology, Eisai Inc., USA

11:10-11:30

Title: Back to the Future: Exploring the Disconnect Between Traditional Chinese Medicine and Western Medical Science.
Dr. Robert Borris, Vice-Dean, School of Pharmaceutical Science and Technology, Tianjin University, China

11:30-11:50

Title: Pulchinenoside D Sensitizes Breast Cancer Cells to Camptothecin Treatment through Interrupting Autophagic-Lysosomal Function and Promoting P62-Mediated Ubiquitinated Protein Aggregation
Dr. Chengwei He,
Associate Professor, Institute of Chinese Medical Sciences, University of Macau,China

11:50-12:10

 

Title: The Hypoglycemic Effect and Mechanism of Tea Polysaccharides and Epigallocatechin-3-O-gallate
Dr. Haixia Chen, Professor, Supervisor of PhD, School of Pharmaceutical Science and Technology, Tianjin University, China

 

12:10-12:30

Title:  Study on Bioactive Molecules from Plant Sources and Their Action Mechanism
Dr. Wei-Lie Xiao, Professor, Yunnan University, China

12:30-12:50

Title: Piper Sarmentosum Roxb. Confers Neuroprotection on Beta-amyloid (Aβ)-Induced Microglia-mediated Neuroinflammation and Attenuates Tau Hyperphosphorylation in SH-SY5Y Cells
Dr. Elaine Wang Ling Chan,
Senior Lecturer, International Medical University, Malaysia

 

Online Registration
Hosting Organizations
Foreign Talent Research Center, MOST

Nanjing Municipal Investment Promotion Bureau

Nanjing Municipal Science and Technology Bureau

District People's Government of Jiangning Nanjing

China Biopharma Parks Cluster Alliance

Jiangsu Pharmaceutical Association
Operating Organizations
China Pharmaceutical University

Nanjing Medical University

Nanjing University of Posts and Telecommunications

Administration Committee of Nanjing Jiangning Hi-Tech Development Zone

Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China
Supporting Organizations
China Association for Technology Innovation

Jiangsu Drug Research and Development Association

Editorial Board of Progress in Pharmaceutical Sciences

Journal of Pharmaceutical and Clinical Research

GenScript Biotechnology Co.,Ltd
Executing Organizations
Nanjing U-FOX Congress Inc.

BIT Congress Inc.
Exhibitors


GenScript Biotechnology Co.,Ltd.



Molnar-Institute for applied chromatography



Chengdu Jian River Pharmaceuticals Co.,Ltd.



Anhui General Biosystems Co.,Ltd.



Molecular Devices, LLC.



Crown Bioscience Inc.
Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.